사용금지 화장품 물질 — 부속서 II
부속서 II는 화장품 원료로 의도적으로 첨가하는 것이 금지된 물질을 나열합니다. 제17조는 별도로, 우수화장품제조관리기준(GMP)과 제3조의 안전 요건에 따라 기술적으로 피할 수 없는 비의도적 미량을 다룹니다. 이 페이지에는 기록 1739건이 있습니다.
이 부속서 필터링
이 부속서의 구성
Annex II is the prohibition list: 1,739 substances that may not be used in cosmetic products in the EU. Article 17 allows for traces that cannot be avoided — it does not allow for adding them.
- 1,739 prohibited substances, 1,018 of them carrying a CMR classification.
- Prohibition covers intentional addition; there is no permitted concentration.
- Article 17 tolerates unintended traces only where they are technically unavoidable under good manufacturing practice and the product remains safe.
- Absence from Annex II is not permission — most substances appear in no annex at all.
Annex II is the shortest kind of answer the regulation gives. A substance listed here may not be used as a cosmetic ingredient, and there is no concentration at which that changes. Where other annexes set limits and conditions, this one sets none, because there is nothing to condition.
The nuance people look for lives in Article 17 rather than in the annex. It provides that the unintended presence of a small quantity of a prohibited substance is permitted where it is technically unavoidable under good manufacturing practice and the product remains safe under Article 3. That is a provision about impurities and residues — what arrives with a raw material, what forms during manufacture, what migrates from packaging. It is not a tolerance to formulate against, and a deliberate addition at a low level is not covered by it.
Just over a thousand of these entries carry a CMR classification — carcinogenic, mutagenic or toxic for reproduction under the CLP Regulation. That is the route by which most of them arrived: Article 15 prohibits CMR substances in cosmetics, with a narrow derogation procedure that is rarely used, so a CLP classification generally becomes an Annex II entry in due course.
The most common misreading is the opposite of the list's own logic. A substance not found in Annex II has not been assessed and permitted. It has not been assessed at all. Most cosmetic ingredients appear in no annex, and their acceptability rests on the safety assessment the responsible person is required to hold.
대조 대상
부속서 II 기록
1739 총| 항목 | 물질 | CAS | 최대 농도 | 표시 |
|---|---|---|---|---|
| 1016 | ZiramCAS 137-30-4 | 137-30-4 | — | |
| 1017 | 1-Bromo-3,4,5-trifluorobenzeneCAS 138526-69-9 | 138526-69-9 | — | CMR |
| 1018 | PropazineCAS 139-40-2 | 139-40-2 | — | CMR |
| 1019 | 3-(4-Chlorophenyl)-1,1-dimethyluronium trichloroacetatemonuron-TCACAS 140-41-0 | 140-41-0 | — | CMR |
| 1020 | IsoxaflutoleCAS 141112-29-0 | 141112-29-0 | — | CMR |
| 1021 | Kresoxim-methylCAS 143390-89-0 | 143390-89-0 | — | CMR |
| 1022 | ChlordeconeCAS 143-50-0 | 143-50-0 | — | CMR |
| 1023 | 9-VinylcarbazoleCAS 1484-13-5 | 1484-13-5 | — | CMR |
| 1024 | 2-ethylhexanoic acid and its salts with the exception of those specified elsewhere in Annex VI to Regulation (EC) No 1272/2008.CAS 149-57-5 / - | 149-57-5 / - | — | CMR |
| 1025 | MonuronCAS 150-68-5 | 150-68-5 | — | CMR |
| 1026 | Morpholine-4-carbonyl chlorideCAS 15159-40-7 | 15159-40-7 | — | CMR |
| 1027 | DaminozideCAS 1596-84-5 | 1596-84-5 | — | |
| 1028 | Alachlor (ISO)CAS 15972-60-8 | 15972-60-8 | — | CMR |
| 1029 | UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamineCAS 166242-53-1 | 166242-53-1 | — | CMR |
| 1030 | 4-hydroxy-3,5-diiodobenzonitrile [1]4-Cyano-2,6-diiodophenyl octanoate [2]CAS 1689-83-4[1] / 3861-47-0[2] | 1689-83-4[1] / 3861-47-0[2] | — | CMR |
| 1031 | Bromoxynil (ISO) 3,5-Dibromo-4-hydroxybenzonitrile [1] and Bromoxynil heptanoate (ISO) [2]CAS 1689-84-5[1] / 56634-95-8[2] | 1689-84-5[1] / 56634-95-8[2] | — | CMR |
| 1032 | 2,6-Dibromo-4-cyanophenyl octanoateCAS 1689-99-2 | 1689-99-2 | — | CMR |
| 1034 | 5-Chloro-1,3-dihydro-2H-indol-2-oneCAS 17630-75-0 | 17630-75-0 | — | CMR |
| 1035 | Benomyl (ISO)CAS 17804-35-2 | 17804-35-2 | — | CMR |
| 1036 | ChlorothalonilCAS 1897-45-6 | 1897-45-6 | — | CMR |
| 1037 | N'-(4-Chloro-o-tolyl)-N,N-dimethylformamidine monohydrochlorideCAS 19750-95-9 | 19750-95-9 | — | CMR |
| 1038 | 4,4'-Methylenebis(2-ethylaniline)CAS 19900-65-3 | 19900-65-3 | — | CMR |
| 1039 | ValinamideCAS 20108-78-5 | 20108-78-5 | — | CMR |
| 1040 | [(p-Tolyloxy)methyl]oxiraneCAS 2186-24-5 | 2186-24-5 | — | CMR |
| 1041 | [(m-Tolyloxy)methyl]oxiraneCAS 2186-25-6 | 2186-25-6 | — | CMR |
| 1042 | 2,3-Epoxypropyl o-tolyl etherCAS 2210-79-9 | 2210-79-9 | — | CMR |
| 1043 | [(Tolyloxy)methyl]oxirane, cresyl glycidyl etherCAS 26447-14-3 | 26447-14-3 | — | CMR |
| 1044 | Di-allateCAS 2303-16-4 | 2303-16-4 | — | CMR |
| 1045 | Benzyl 2,4-dibromobutanoateCAS 23085-60-1 | 23085-60-1 | — | CMR |
| 1046 | TrifluoroiodomethaneCAS 2314-97-8 | 2314-97-8 | — | CMR |
| 1047 | Thiophanate-methylCAS 23564-05-8 | 23564-05-8 | — | CMR |
| 1048 | Dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane (Mirex)CAS 2385-85-5 | 2385-85-5 | — | CMR |
| 1049 | PropyzamideCAS 23950-58-5 | 23950-58-5 | — | CMR |
| 1050 | Butyl glycidyl etherCAS 2426-08-6 | 2426-08-6 | — | CMR |
| 1051 | 2,3,4-Trichlorobut-1-eneCAS 2431-50-7 | 2431-50-7 | — | CMR |
| 1052 | ChinomethionateCAS 2439-01-2 | 2439-01-2 | — | CMR |
| 1053 | (R)-alpha-Phenylethylammonium (-)-(1R,2S)-(1,2-epoxypropyl)phosphonate monohydrateCAS 25383-07-7 | 25383-07-7 | — | CMR |
| 1054 | 5-Ethoxy-3-trichloromethyl-1,2,4-thiadiazole (Etridiazole - ISO)CAS 2593-15-9 | 2593-15-9 | — | CMR |
| 1055 | Disperse Yellow 3CAS 2832-40-8 | 2832-40-8 | — | CMR |
| 1056 | 1,2,4-TriazoleCAS 288-88-0 | 288-88-0 | — | CMR |
| 1057 | Aldrin (ISO)CAS 309-00-2 | 309-00-2 | — | CMR |
| 1058 | Diuron (ISO)CAS 330-54-1 | 330-54-1 | — | CMR |
| 1059 | Linuron (ISO)CAS 330-55-2 | 330-55-2 | — | CMR |
| 1060 | Nickel carbonatebasic nickel carbonate; carbonic acid, nickel (2+) salt [1]; carbonic acid, nickel salt [2]; [micro-[carbonato(2-)-O:O']]dihydroxy trinickel [3]; [carbonato(2-)]tetrahydroxytrinickel [4]CAS 3333-67-3[1] / 16337-84-1[2] / 65405-96-1[3] / 12607-70-4[4] | 3333-67-3[1] / 16337-84-1[2] / 65405-96-1[3] / 12607-70-4[4] | — | CMR |
| 1061 | 3-(4-Isopropylphenyl)-1,1-dimethylurea (Isoproturon - ISO)CAS 34123-59-6 | 34123-59-6 | — | CMR |
| 1062 | IprodioneCAS 36734-19-7 | 36734-19-7 | — | CMR |
| 1064 | 5-(2,4-Dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethylterahydrofuranCAS 41107-56-6 | 41107-56-6 | — | CMR |
| 1065 | Crotonaldehyde [1](E)-crotonaldehyde [2]CAS 4170-30-3[1] / 123-73-9[2] | 4170-30-3[1] / 123-73-9[2] | — | CMR |
| 1066 | Hexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide | — | — | CMR |
| 1067 | 4,4'-Carbonimidoylbis[N,N-dimethylaniline] and its saltsCAS 492-80-8 | 492-80-8 | — | CMR |
이 그룹별 보기 사용 방법
부속서 II에는 화장품에 사용이 금지된 물질이 포함되어 있습니다. 사용금지 물질 기록 1739건을 명칭, 식별자 및 연결된 항목 페이지별로 빠르게 훑어보려면 이 그룹별 보기를 이용하세요.
법적 문구 전문, 농도 논리, 경고 문구 또는 관련 식별자 링크가 필요하면 개별 기록을 여세요.